Opko Health
OPK
234 hedge funds and large institutions have $279M invested in Opko Health in 2024 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 55 increasing their positions, 64 reducing their positions, and 31 closing their positions.
23% more capital invested
Capital invested by funds: $228M → $279M (+$51.8M)
13% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 31
1% more funds holding
Funds holding: 232 → 234 (+2)
0.64% more ownership
Funds ownership: 26.13% → 26.77% (+0.64%)
14% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 64
32% less call options, than puts
Call options by funds: $16.3M | Put options by funds: $23.9M
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$6.36M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.2M |
| 3 |
Millennium Management
New York
|
+$1.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.45M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.3M |
Top Sellers
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$2.36M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$1.44M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$1.38M |
| 4 |
Charles Schwab
San Francisco,
California
|
-$1.24M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.24M |
OPK Hedge Fund Activity: Q3 2024 in Review
234 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q3 2024, worth a combined $279M — up 23% from $228M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new OPK positions and 31 closed out — a net gain of 4 holders — while 55 added to existing stakes and 64 trimmed.
The largest buyer was Rubric Capital Management (New York), adding an estimated $6.36M. The largest seller was Portolan Capital Management, exiting entirely with an estimated $2.36M sold.
- 234 institutional investors held Opko Health (OPK) as of Q3 2024, up from 232 in Q2 2024.
- Funds reported $279M of Opko Health stock for Q3 2024, up 23% quarter-over-quarter.
- 35 funds opened new Opko Health positions in Q3 2024 and 31 closed out, a net change of +4 holders.
- The largest Opko Health buyer in Q3 2024 was Rubric Capital Management (New York), an estimated $6.36M added.
- The largest Opko Health seller in Q3 2024 was Portolan Capital Management, an estimated $2.36M sold.
Based on aggregated 13F filings for Q3 2024.